You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
亨迪藥業(301211.SZ):未來將繼續深耕解熱鎮痛等傳統優勢領域,同時關注相關領域如止咳、痛風等新興熱點
格隆匯 06-14 15:19

格隆匯6月14日丨亨迪藥業(301211.SZ)於2024年6月13日接受特定對象調研,就“請介紹一下公司非甾體抗炎藥領域的研發成果及影響”,公司回覆稱,公司長期專注於布洛芬及其系列產品的研發,產品線覆蓋原料藥、中間體、製劑等多個環節,形成了完整的產業鏈佈局。通過持續的工藝優化和質量提升,公司在全球布洛芬供應商中處於領先地位。未來公司將繼續深耕解熱鎮痛等傳統優勢領域,同時關注相關領域如止咳、痛風等新興熱點,豐富管線儲備。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account